CDEK
← All organizations

Warner Chilcott

For profitContributed to NME

Also known as: WARNER CHILCOTT | Warner Chilcott Laboratories | WARNER CHILCOTT LLC | Warner Chilcott (US) LLC | Warner Chilcott (v2)

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2000

First marketed drug

Jan 1, 1996

Last known activity

Feb 1, 2016

Acquired by Actavis → Allergan PLC (2015) → AbbVie on Jan 1, 2013

Timeline

1970s

  1. Feb 17, 1978

    cefadroxil— NDA Organization

1990s

  1. Jan 1, 1996

    Warner Chilcott— Founded

  2. Jan 1, 1996

    Nalé Laboratories, PLC— Acquired

2000s

  1. Jan 1, 2000

    Galen— Acquired

  2. Aug 12, 2005

    calcium carbonate— NDA Secondary Org

  3. Aug 12, 2005

    risedronate— Marketing Organization

  4. Jan 1, 2009

    Procter and Gamble— Acquired

2010s

  1. Jan 1, 2013

    Actavis— Acquired By

  2. Jun 26, 2019

    AbbVie— Now

Drugs by trial phase (67 distinct, 161 trials)

Phase 1 (0 own, 4 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (43)

Subsidiaries (3 direct, 13 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Dublin, IE Jan 1, 1996
Last known activity
Feb 1, 2016

Notes

Acquired by Actavis 20 May 2013